Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

1. Advancements in risk stratification and management strategies in primary cardiovascular prevention

   Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush +25

   Sharh maqolaLipoproteins and Cardiovascular HealthAtherosclerosis20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.review-article.000004

2. Peptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials

   Haniyeh Barzgar, Darmadi Darmadi, Jabbarova Nafisa +2

   Sharh maqolaDiabetes Treatment and ManagementClinica Chimica Acta20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.review-article.000250